Everything below concerns half-life. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-21. Numbers and descriptions here follow the published literature rather than marketing material.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | Not a small molecule |
| Backbone substitutions | Non-natural residue at position 8, arginine at position 34 | Slows enzymatic cleavage |
| Side chain | C18 fatty diacid with PEG linker | Enables albumin binding |
| Approximate molecular mass | 4114 Da | Varies slightly with salt form |
| Reported half-life | About one week | Longer than native GLP-1 by orders of magnitude |
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
肽类的主要降解路径包括天冬酰胺脱酰胺、甲硫氨酸氧化、天冬氨酸异构化以及由 β-折叠驱动的聚集，这些反应对 pH 与缓冲液种类较为敏感。磷酸盐、丙二醇与苯酚等辅料会影响局部微环境与界面行为。强制降解研究借助高温、强光、氧化剂与极端 pH 暴露来预测产物谱。关于长期室温存放的数据相对有限，超出标签条件的稳定性仍属开放问题，需要在具体制剂中通过实时与加速试验加以确认。
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
Solid peptide material is generally kept at reduced temperature to limit degradation. Short-term storage at 2 to 8 degrees Celsius is common, while longer archival storage at minus 20 degrees Celsius or below is typical for lyophilised powder. Vials should remain sealed and protected from light, because ultraviolet exposure can oxidise susceptible residues. Repeated freeze-thaw cycles are avoided, as they promote aggregation and loss of soluble material. Solutions are less stable than solids and are usually prepared close to the time of use.
Reversed-phase high-performance liquid chromatography is widely used to assess purity and to separate the parent peptide from related substances. Mass spectrometry confirms identity and can resolve modifications that differ by a few daltons. Size-exclusion chromatography detects dimers and higher aggregates, which are relevant to both stability and immunogenicity questions. Peptide mapping with enzymatic digestion locates specific modifications along the sequence. Circular dichroism provides a secondary-structure profile, although it gives limited information about local conformational changes.
Quality control for peptide material focuses on identity, purity, content and the profile of impurities. Common degradants include deamidated and oxidised forms, plus aggregates formed during storage or handling. Forced degradation studies under heat, light, acid and peroxide help define which conditions accelerate change and which analytical methods detect it. Limits for individual impurities are set by pharmacopoeial monographs or manufacturer specifications. How much a given impurity affects biological activity is often uncertain, and conclusions may depend on the assay used.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nm is the standard purity method, reported as area percent. Mass spectrometry, usually with electrospray ionisation, confirms identity and reveals covalent modifications. Size-exclusion chromatography quantifies aggregates and fragments. Peptide mapping after enzymatic digestion localises changes to specific sequence regions. Circular dichroism and infrared spectroscopy report on secondary structure, while light scattering tracks particle formation in liquid formulations. No single technique captures every quality attribute.
Quality control relies on pharmacopoeial monographs where they exist, combined with in-house specifications for identity, purity, water content, and counter-ion composition. Reference standards allow calibration across laboratories, although certified materials for every analogue are not universally obtainable. Batch records, chromatograms, and mass spectra form the documentation trail. Regulatory classification varies by jurisdiction and intended use, and research-grade material differs from pharmaceutical-grade material in testing scope. Analytical uncertainty is often expressed as relative standard deviation across replicate injections.
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
The appearance of the princess before the judge took place on February 8 amid great national and international media expectation. The impact on public opinion was reflected in the CIS barometer of May, in which the monarchy failed again with a score of 3.72. On June 2, 2014, the abdication of Juan Carlos was announced, after nearly 39 years of reign. He had taken the decision five months earlier, on January 5, his birthday, and had communicated it to Prime Minister Mariano Rajoy on March 31. Pro-republicans reacted to the abdication by holding rallies in several cities calling for a referendum to decide the form of government. This claim reappeared in the debate held in the Congress of Deputies on June 11 to approve the organic abdication law. It was presented and supported by the formations that voted against said law: the 19 seats that made up United Left-Plural Left, Geroa Bai, Compromís, New Canaries, Republican Left of Catalonia and BNG. The law was approved by an overwhelming majority: 299 deputies of the PP, PSOE, UPyD, Asturias Forum and Navarrese People's Union. On June 18, Juan Carlos signed the law, which was the last official act of his reign. The following day, Felipe VI was proclaimed King by the Cortes.
Gokhan Okan, Can Baykal, Rifkiye Sarica. "Childhood bullous pemphigoid developed after the first vaccination." Journal of Dermatological Treatment Gokhan Okan, Pervin Vural. "Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID‐19 vaccine." Journal of Dermatological Treatment Gokhan Okan, Adile Merve Baki, Eda Yorulmaz, Semra Doğru‐Abbasoğlu, and Pervin Vural. "Serum Visfatin, Fetuin‐A, and Pentraxin 3 Levels in Patients with Psoriasis and Their Relation to Disease Severity". Journal of clinical laboratory analysis. Gokhan Okan, and Halil Ibrahim Canter. "Nicolau syndrome and perforator vessels: a new viewpoint for an old problem". Journal of Cutaneous and Ocular Toxicology. Gokhan Okan, and Can Baykal. "Nevoid hyperkeratosis of the nipple and areola: treatment with topical retinoic acid". Journal of the European Academy of Dermatology and Venereology. Gokhan Okan, Serpil Yaylaci, Onder Peker, Sabahattin Kaymakoglu, and Murat Saruc. "Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus". World Journal of gastroenterology. Can Baykal, Gökhan Okan, and Rifkiye Sarica. "Childhood bullous pemphigoid developed after the first vaccination". Journal of the American Academy of Dermatology. Gökhan Okan, "Atopik dermatitin baş boyun lokalizasyonlarında pityrosporum ovalenin rolü". ("The role of pityrosporum ovalen in head and neck localization of atopic dermatitis.") Gokhan Okan, Adile Merve Baki, Eda Yorulmaz, Semra Dogru-Abbasoglu, Pervin vural.
Polycarbodiimides can also be used as crosslinkers for aqueous resins, such as polyurethane dispersions or acrylic dispersion. Here the polycarbodiimide reacts with carboxylic acids, whose functional groups are often present in such aqueous resins, to form N-acyl urea. The result is the formation of covalent bonds between the polymer chains, making them crosslinked.
Sources: en.wikipedia.org
Ari and Mac struggle to find time to be together with Mia and Chloe in the Bay. Mac tries to be supportive, but it becomes clear that there are unresolved issues between Ari and Mia. Kipa-Williams told Sarah Ellis of Inside Soap that Ari had no romantic intentions towards Mia, as he is happy with Mac, but then a sense of familiarity creeps in and being with Mia is "second nature" to Ari. Ari later invites Mia to a barbeque at the Parata house, but forgets to tell Mac, who learns about the event from Mia. Mac later sees Ari and Mia sharing a private moment together in the yard. Kipa-Williams said that Mia's presence has stirred up memories of the past that his character thought he had buried. While Samson commented that Mia does not want to get in the way of Ari's relationship and she has "no bad feelings" towards Mac. Ari later ends the relationship because of his unresolved feelings for Mia. Kipa-Williams told TV Week's Stephen Downie "After spending time in prison, Ari has decided to live by a new set of rules and tries to be as honest as possible. He loves Mia and Mac, which is why he needs to break up with Mac and figure out his feelings for Mia and what her being here means to him." In an interview with Susannah Alexander and Daniel Kilkelly of Digital Spy, Kipa-Williams expressed his disappointment about Mac and Ari's break up. He admitted that he was "really sad about it", as he enjoyed the bond he had formed with Weir and wanted their characters to become "a solid couple" similar to Ben Astoni (Rohan Nichol) and Maggie Astoni (Kestie Morassi).
==== Gene and protein expression ==== Approximately 20,000 protein coding genes are expressed in human cells and 75% of these genes are expressed in at least one of the different parts of the digestive organ system. Over 600 of these genes are more specifically expressed in one or more parts of the GI tract and the corresponding proteins have functions related to digestion of food and uptake of nutrients. Examples of specific proteins with such functions are pepsinogen PGC and the lipase LIPF, expressed in chief cells, and gastric ATPase ATP4A and gastric intrinsic factor GIF, expressed in parietal cells of the stomach mucosa. Specific proteins expressed in the stomach and duodenum involved in defence include mucin proteins, such as mucin 6 and intelectin-1.
== Natural occurrences == Synephrine, although already known as a synthetic organic compound, was first isolated as a natural product from the leaves of various Citrus trees, and its presence noted in different Citrus juices, by Stewart and co-workers in the early 1960s. A survey of the distribution of synephrine amongst the higher plants was published in 1970 by Wheaton and Stewart. It has subsequently been detected in Evodia and Zanthoxylum species, all plants of the family Rutaceae. Trace levels (0.003%) of synephrine have also been detected in the dried leaves of Pogostemon cablin (patchouli, Lamiaceae). It is also found in certain cactus species of the genera Coryphantha and Dolichothele. However, this compound is found predominantly in a number of Citrus species, including "bitter" orange varieties.
Sources: en.wikipedia.org
The Parliament of Canada passes all federal statute laws. It comprises the monarch, the House of Commons, and the Senate. While Canada inherited the British concept of parliamentary supremacy, this was later, with the enactment of the Constitution Act, 1982, all but completely superseded by the American notion of the supremacy of the law. Each of the 343 members of Parliament in the House of Commons is elected by simple plurality in an electoral district or riding. The Constitution Act, 1982, requires that no more than five years pass between elections, although the Canada Elections Act limits this to four years with a "fixed" election date in October; general elections still must be called by the governor general and can be triggered by either the advice of the prime minister or a lost confidence vote in the House. The 105 members of the Senate, whose seats are apportioned on a regional basis, serve until age 75. Canadian federalism divides government responsibilities between the federal government and the 10 provinces. Provincial legislatures are unicameral and operate in parliamentary fashion similar to the House of Commons. Canada's three territories also have legislatures, but these are not sovereign, have fewer constitutional responsibilities than the provinces, and differ structurally from their provincial counterparts.
== Philanthropy == Kimmel was an important benefactor of New York University donating $10 million in 2005 and $15 million in 2006 to fund the Helen and Martin Kimmel Center for Stem Cell Biology, creating a professorship of molecular immunology, and contributing to the construction of the Helen and Martin Kimmel Center for University Life which houses the Skirball Center for the Performing Arts. Kimmel is also a significant contributor to the Weizmann Institute of Science in Rehovot, Israel funding the Helen and Martin Kimmel Institute for Magnetic Resonance, the Helen and Martin Kimmel Center for Molecular Design, the Helen and Martin Kimmel Hyperbaric & Advanced Wound Healing Center, and the Kimmel Center for Archaeological Science. Kimmel was a long time supporter of the Jewish Museum in New York City. Kimmel served as a trustee of New York University Langone Medical Center.
The three substrates of this enzyme are 3''-deamino-3''-oxonicotianamine, reduced nicotinamide adenine dinucleotide (NADH), and a proton. Its products are 2'-deoxymugineic acid and oxidised (NAD+). This enzyme can also use the alternative cofactor, nicotinamide adenine dinucleotide phosphate. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 2-deoxymugineic acid:NAD(P)+ 3-oxidoreductase. It is part of the pathway which converts the siderophore, nicotianamine, to other metal-chelating molecules in higher plants. These allow the plant to efficiently take up metals such as zinc and iron from the soil.
== Regulation == Protein concentration, which in turn are affected by expression levels and degradation rates; Protein affinity for proteins or other binding ligands; Ligands concentrations (substrates, ions, etc.); Presence of other proteins, nucleic acids, and ions; Electric fields around proteins. Occurrence of covalent modifications;
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.
Albumin binding keeps a large fraction of the compound in a slowly released reservoir within the bloodstream. Plasma levels decline gradually rather than falling sharply after each administration. That profile supports dosing intervals measured in days instead of hours.
The active peptide sequence is the same in both formats. The oral version adds an absorption enhancer that is not present in the injected solution. Differences in excipients and formulation affect uptake rather than the identity of the active molecule.
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.